|
Market Closed -
Other stock markets
|
After market 12:33:31 | |||
| 16.36 EUR | -0.12% |
|
16.35 | -0.06% |
| 05-15 | Medincell: share price falls after disappointing clinical study | CF |
| 05-15 | Transcript : MedinCell S.A. - Special Call |
May 8 (Reuters) - Teva Pharmaceuticals and partner Medincell said on Wednesday their experimental schizophrenia drug had met its main goal in a late-stage study. (Reporting by Puyaan Singh; Editing by Devika Syamnath)
| 1st Jan change | Capi. | |
|---|---|---|
| +127.22% | 516M | |
| +39.97% | 734B | |
| +32.83% | 591B | |
| -6.09% | 350B | |
| +15.02% | 315B | |
| +1.42% | 276B | |
| +15.00% | 238B | |
| +9.78% | 206B | |
| -5.52% | 204B | |
| +5.60% | 161B |
MEDINCELL S.A. 
